Highlights and Quick Summary
- Total non-current liabilities for the quarter ending March 31, 2022 was $1.27 Million (a -95.01% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities decreased by -97.37%
- Annual Total non-current liabilities for 2021 was $1.46 Million (a -96.86% decrease from previous year)
- Annual Total non-current liabilities for 2020 was $46.5 Million (a 12.79% increase from previous year)
- Annual Total non-current liabilities for 2019 was $41.2 Million (a 132.74% increase from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of Biofrontera AG Sponsored ADR
Most recent Total non-current liabilitiesof BFAGY including historical data for past 10 years.Interactive Chart of Total non-current liabilities of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | $1.27 | – |
| 2021 | – | $25.45 | $48.3 | $48.23 | $1.46 |
| 2020 | – | $55.86 | $43.23 | $40.37 | $46.53 |
| 2019 | – | – | $46.54 | $25.62 | $41.25 |
| 2018 | – | – | – | $15.39 | $17.72 |
| 2017 | – | – | $14.98 | $9.22 | $13.96 |
| 2016 | $3.98 | – | – | – | $3.98 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic